Denovo Interactions
There are 25 drugs known to interact with Denovo (l-methylfolate), along with 1 disease interaction. Of the total drug interactions, 3 are major, 21 are moderate, and 1 is minor.
- View Denovo disease interactions (1)
Medications known to interact with Denovo
Note: Showing generic names only.
- capecitabine
- carbamazepine
- divalproex sodium
- eslicarbazepine
- ethosuximide
- ethotoin
- felbamate
- fluorouracil
- fosphenytoin
- lamotrigine
- mephenytoin
- mephobarbital
- methotrexate
- methsuximide
- oxcarbazepine
- pafolacianine
- pancreatin
- pancrelipase
- phenobarbital
- phensuximide
- phenytoin
- primidone
- rufinamide
- sulfasalazine
- valproic acid
Denovo disease interactions
There is 1 disease interaction with Denovo (l-methylfolate) which include:
Report options
More about Denovo (l-methylfolate)
- Denovo consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vitamins
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Deplin
Deplin is used for depression, folate deficiency, hyperhomocysteinemia
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Folacin-800
Folacin-800 is used for anemia, megaloblastic, folate deficiency, vitamin/mineral supplementation ...
Folic acid
Folic acid (vitamin B9) is a B vitamin supplement that may be used to prevent and treat folate ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.